BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 121 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $88,000 | +17.3% | 25,673 | -1.9% | 0.00% | 0.0% |
| Q3 2019 | $75,000 | +2400.0% | 26,173 | +4101.1% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 623 | +27.4% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 489 | +25.7% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 389 | -20.4% | 0.00% | – |
| Q3 2018 | $4,000 | +100.0% | 489 | +25.7% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 389 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 389 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | -96.6% | 389 | -98.1% | 0.00% | -100.0% |
| Q2 2016 | $58,000 | +100.0% | 20,389 | +96.3% | 0.00% | 0.0% |
| Q1 2016 | $29,000 | +625.0% | 10,389 | +2570.7% | 0.00% | – |
| Q4 2015 | $4,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q3 2015 | $4,000 | -96.4% | 389 | -94.7% | 0.00% | -100.0% |
| Q2 2015 | $110,000 | +214.3% | 7,389 | +90.0% | 0.00% | +100.0% |
| Q1 2015 | $35,000 | -18.6% | 3,889 | +11.1% | 0.00% | 0.0% |
| Q4 2014 | $43,000 | +48.3% | 3,500 | +16.7% | 0.00% | 0.0% |
| Q3 2014 | $29,000 | -23.7% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $38,000 | +375.0% | 3,000 | +200.0% | 0.00% | – |
| Q4 2013 | $8,000 | +14.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2013 | $7,000 | -83.7% | 1,000 | -96.4% | 0.00% | -100.0% |
| Q2 2013 | $43,000 | – | 28,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $62,538,000 | 25.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,733 | $27,979,000 | 5.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 57,000 | $19,282,000 | 4.35% |
| MPM BioImpact LLC | 639,089 | $10,392,000 | 2.79% |
| Parkman Healthcare Partners LLC | 476,978 | $7,756,000 | 2.27% |
| Sarissa Capital Management LP | 1,390,790 | $22,614,000 | 2.14% |
| Ghost Tree Capital, LLC | 350,000 | $5,691,000 | 1.24% |
| Lisanti Capital Growth, LLC | 662,644 | $10,775,000 | 1.21% |
| Baker Brothers Advisors | 12,710,818 | $206,678,000 | 1.19% |
| Tamarack Advisers, LP | 125,000 | $2,033,000 | 0.96% |